NextMed Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 159

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

NextMed General Information

Description

Developer of lithotripsy technology intended to provide unsurpassed lithotripsy services, surgical laser, and endoscopic services through innovation and education, with measurable results. The company's technology provides physicians with the information they need to choose the equipment and treatment protocols for their regions by using a stone disease registry and data analytics, enabling urologists to increase treatment protocol effectiveness and revolutionize patient care with superior service and technology.

Contact Information

Website
www.nextmed.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Decision/Risk Analysis
Corporate Office
  • 6339 East Speedway Boulevard
  • Suite 201
  • Tucson, AZ 85710
  • United States
+1 (800) 000-0000

NextMed Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NextMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 31-Oct-2022 Cancelled Generating Revenue
6. Later Stage VC 11-Apr-2022 00000 00000 Completed Generating Revenue
5. Later Stage VC 06-Jan-2021 0000 00000 Completed Generating Revenue
4. Later Stage VC 03-Oct-2018 00000 00000 Completed Generating Revenue
3. Later Stage VC 06-Nov-2015 0000 00000 Completed Generating Revenue
2. Later Stage VC 02-Jun-2015 $105K $305K Completed Generating Revenue
1. Later Stage VC 18-Dec-2009 $200K $200K Completed Generating Revenue
To view NextMed’s complete valuation and funding history, request access »

NextMed Patents

NextMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D472335-S1 Torch radio Inactive 13-Jun-2002
US-6985869-B1 Digital prescription carrier and monitor system Inactive 21-Jan-2000 000000000 00

NextMed Executive Team (6)

Name Title Board Seat Contact Info
Christopher Gleason Chief Executive Officer & President
Matthew Gleason Co-Founder & Partner
John Waechter Director of Operations
Scott Hallett Director of Sales & Marketing
You’re viewing 4 of 6 executive team members. Get the full list »

NextMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NextMed FAQs

  • When was NextMed founded?

    NextMed was founded in 1996.

  • Who is the founder of NextMed?

    Matthew Gleason is the founder of NextMed.

  • Who is the CEO of NextMed?

    Christopher Gleason is the CEO of NextMed.

  • Where is NextMed headquartered?

    NextMed is headquartered in Tucson, AZ.

  • What is the size of NextMed?

    NextMed has 159 total employees.

  • What industry is NextMed in?

    NextMed’s primary industry is Diagnostic Equipment.

  • Is NextMed a private or public company?

    NextMed is a Private company.

  • What is NextMed’s current revenue?

    The current revenue for NextMed is 00000.

  • How much funding has NextMed raised over time?

    NextMed has raised $662K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »